NeuroPace Goodwill and Intangible Assets 2020-2025 | NPCE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroPace goodwill and intangible assets from 2020 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NeuroPace goodwill and intangible assets from 2020 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$184.3B
Intuitive Surgical (ISRG)	$168.9B
IDEXX Laboratories (IDXX)	$51.3B
Edwards Lifesciences (EW)	$47.5B
Alcon (ALC)	$40.1B
IQVIA Holdings (IQV)	$32.1B
DexCom (DXCM)	$30B
Mettler-Toledo (MTD)	$26.5B
STERIS (STE)	$24.5B
Waters (WAT)	$17.5B
SONOVA HOLDING (SONVY)	$17B
Hologic (HOLX)	$14.8B
Penumbra (PEN)	$10.4B
Globus Medical (GMED)	$8.3B
Sysmex ADR (SSMXY)	$8.1B
Masimo (MASI)	$7.7B
Teleflex (TFX)	$5.7B
Glaukos (GKOS)	$5.5B
TransMedics (TMDX)	$4B
Integer Holdings (ITGR)	$3.8B
LivaNova (LIVN)	$3.1B
Alphatec Holdings (ATEC)	$2.4B
PROCEPT BioRobotics (PRCT)	$2.3B
Veracyte (VCYT)	$2.3B
Artivion (AORT)	$2.1B
Nihon Kohden (NHNKY)	$1.9B
Elekta AB (EKTAY)	$1.9B
Integra LifeSciences Holdings (IART)	$1.2B
OPKO Health (OPK)	$1.1B
Paragon 28 (FNA)	$1.1B